We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Tactile Systems Technology
TCMD
$642M
| $17.9M | 0.15% |
315,248
-15,607
| -5% | -$814K |
|
|
ANSS
152
DELISTED
Ansys
ANSS
| $17.9M | 0.15% |
87,346
-315,813
| -78% | -$60.2M |
|
153
Teva Pharmaceuticals
TEVA
$40.1B
| $17.9M | 0.15% |
+1,935,491
| New | +$23.3M |
|
|
DOO
154
Bombardier Recreational Products
DOO
$4.52B
| $17.4M | 0.14% |
485,192
-189,732
| -28% | -$5.9M |
|
155
QuidelOrtho
QDEL
$1.15B
| $17.4M | 0.14% |
292,509
-19,211
| -6% | -$1.15M |
|
|
WNS
156
DELISTED
WNS Holdings
WNS
| $17.3M | 0.14% |
292,641
+31,432
| +12% | +$1.77M |
|
157
Republic Services
RSG
$67.5B
| $17.1M | 0.14% |
197,849
+196,232
| +12,136% | +$16.3M |
|
|
SPR
158
DELISTED
Spirit AeroSystems
SPR
| $17.1M | 0.14% |
+210,514
| New | +$17.7M |
|
|
TWNK
159
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $17.1M | 0.14% |
1,184,360
+1,085,843
| +1,102% | +$14.5M |
|
|
PACW
160
DELISTED
PacWest Bancorp
PACW
| $17M | 0.14% |
438,961
-55,546
| -11% | -$2.15M |
|
161
Alnylam Pharmaceuticals
ALNY
$38.5B
| $17M | 0.14% |
+234,539
| New | +$18M |
|
162
VF Corp
VFC
$5.93B
| $17M | 0.14% |
+194,448
| New | +$16.8M |
|
|
CUK
163
DELISTED
Carnival PLC
CUK
| $17M | 0.14% |
374,939
-56,171
| -13% | -$2.88M |
|
164
Vertex Pharmaceuticals
VRTX
$125B
| $16.9M | 0.14% |
92,285
+30,053
| +48% | +$5.25M |
|
|
SKX
165
DELISTED
Skechers
SKX
| $16.8M | 0.14% |
533,785
+74,345
| +16% | +$2.29M |
|
166
Wingstop
WING
$3.82B
| $16.8M | 0.14% |
177,174
+106,193
| +150% | +$8.65M |
|
167
Crane NXT
CXT
$3.05B
| $16.6M | 0.14% |
+573,724
| New | +$16.7M |
|
168
Arbor Realty Trust
ABR
$987M
| $16.5M | 0.14% |
1,365,306
+1,233,920
| +939% | +$16M |
|
169
Booking.com
BKNG
$154B
| $16.2M | 0.13% |
+216,325
| New | +$15.5M |
|
|
SFIX
170
Stitch Fix
SFIX
$567M
| $16.2M | 0.13% |
507,025
+484,247
| +2,126% | +$13M |
|
|
UMPQ
171
DELISTED
Umpqua Holdings Corp
UMPQ
| $16.2M | 0.13% |
975,186
-134,823
| -12% | -$2.28M |
|
172
Coca-Cola
KO
$390B
| $16.1M | 0.13% |
+316,978
| New | +$15.5M |
|
|
SRC
173
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $16.1M | 0.13% |
377,954
+216,555
| +134% | +$9.14M |
|
174
Microsoft
MSFT
$2.9T
| $16M | 0.13% |
119,667
+14,844
| +14% | +$1.88M |
|
175
Zebra Technologies
ZBRA
$13.6B
| $16M | 0.13% |
76,399
+18,733
| +32% | +$3.78M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.